(STLAP) Stellantis - Overview
Sector: Consumer Cyclical | Industry: Auto Manufacturers | Exchange: PA (France) | Market Cap: 17.028m EUR | Total Return: -23.1% in 12m
Stock
Automobiles, Trucks, Engines, Parts, Services
Total Rating 17
Safety 35
Buy Signal -0.63
Market Cap:
19,735m
Avg Trading Vol: 25.4M EUR
Avg Trading Vol: 25.4M EUR
ATR:
4.40%
Peers RS (IBD): 6.8
Peers RS (IBD): 6.8
Risk 5d forecast
Volatility43.4%
Rel. Tail Risk-9.06%
Reward TTM
Sharpe Ratio-0.37
Alpha-48.38
Character TTM
Beta1.073
Beta Downside0.953
Drawdowns 3y
Max DD76.17%
CAGR/Max DD-0.29
Risks
Technicals:
volatile low_hurst
Description: STLAP Stellantis
Stellantis N.V. operates globally, designing, engineering, manufacturing, and distributing automobiles and light commercial vehicles. The company also produces engines, transmission systems, and metallurgical products.
Its product portfolio includes luxury, premium, global SUV, American, and European brand vehicles, along with parts and accessories. Stellantis offers contract services, retail and dealer financing, and leasing and rental services. The automotive manufacturing sector is characterized by significant capital expenditure and a complex global supply chain.
Stellantis markets its products under numerous brands, including Abarth, Alfa Romeo, Chrysler, Citroën, DS, Dodge, FIAT, Jeep, Maserati, Ram, Opel, Lancia, Vauxhall, Peugeot, and Comau. Distribution occurs through a network of distributors and dealers. To understand the companys competitive landscape and financial health, further research on platforms like ValueRay is recommended.
- Global vehicle sales volume impacts revenue
- Raw material costs influence production expenses
- Regulatory emissions standards affect product development
- Consumer demand for electric vehicles drives investment
- Currency exchange rates impact international earnings
Piotroski VR‑10 (Strict)
3.0
| Net Income: -18.51b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.07 > 0.02 and ΔFCF/TA -11.96 > 1.0 |
| NWC/Revenue: 0.78% < 20% (prev 4.71%; Δ -3.94% < -1%) |
| CFO/TA -0.01 > 3% & CFO -1.56b > Net Income -18.51b |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.02 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.89b) vs 12m ago -4.42% < -2% |
| Gross Margin: 2.69% > 18% (prev 0.20%; Δ 248.9% > 0.5%) |
| Asset Turnover: 115.4% > 50% (prev 112.2%; Δ 3.22% > 0%) |
| Interest Coverage Ratio: -7.39 > 6 (EBITDA TTM -9.90b / Interest Expense TTM 2.58b) |
Altman Z''
0.71
| A: 0.01 (Total Current Assets 80.54b - Total Current Liabilities 78.74b) / Total Assets 195.15b |
| B: 0.27 (Retained Earnings 53.27b / Total Assets 195.15b) |
| C: -0.09 (EBIT TTM -19.08b / Avg Total Assets 201.02b) |
| D: 0.38 (Book Value of Equity 53.84b / Total Liabilities 141.15b) |
| Altman-Z'' Score: 0.71 = B |
Beneish M
1.00
| DSRI: 3.15 (Receivables 21.81b/6.92b, Revenue 231.95b/232.05b) |
| GMI: 7.34 (GM 2.69% / 19.71%) |
| AQI: 0.97 (AQ_t 0.37 / AQ_t-1 0.38) |
| SGI: 1.00 (Revenue 231.95b / 232.05b) |
| TATA: -0.09 (NI -18.51b - CFO -1.56b) / TA 195.15b) |
| Beneish M-Score: 4.38 (Cap -4..+1) = D |
What is the price of STLAP shares?
As of April 04, 2026, the stock is trading at EUR 6.07 with a total of 2,892,643 shares traded.
Over the past week, the price has changed by +11.90%, over one month by +6.17%, over three months by -31.60% and over the past year by -23.06%.
Over the past week, the price has changed by +11.90%, over one month by +6.17%, over three months by -31.60% and over the past year by -23.06%.
Is STLAP a buy, sell or hold?
Stellantis has no consensus analysts rating.
What are the forecasts/targets for the STLAP price?
| Wallstreet Target Price | 8.5 | 40% |
| Analysts Target Price | - | - |
STLAP Fundamental Data Overview
as of 30 March 2026
Market Cap USD = 19.74b (17.03b EUR * 1.159 EUR.USD)P/E Forward = 7.8309
P/S = 0.1109
P/B = 0.3179
P/EG = 1.2758
Revenue TTM = 231.95b EUR
EBIT TTM = -19.08b EUR
EBITDA TTM = -9.90b EUR
Long Term Debt = 30.19b EUR (from longTermDebt, last quarter)
Short Term Debt = 14.12b EUR (from shortTermDebt, last quarter)
Debt = 45.95b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 15.80b EUR (from netDebt column, last quarter)
Enterprise Value = 31.60b EUR (17.03b + Debt 45.95b - CCE 31.37b)
Interest Coverage Ratio = -7.39 (Ebit TTM -19.08b / Interest Expense TTM 2.58b)
EV/FCF = -2.31x (Enterprise Value 31.60b / FCF TTM -13.70b)
FCF Yield = -43.35% (FCF TTM -13.70b / Enterprise Value 31.60b)
FCF Margin = -5.91% (FCF TTM -13.70b / Revenue TTM 231.95b)
Net Margin = -7.98% (Net Income TTM -18.51b / Revenue TTM 231.95b)
Gross Margin = 2.69% ((Revenue TTM 231.95b - Cost of Revenue TTM 225.72b) / Revenue TTM)
Gross Margin QoQ = -6.32% (prev 8.45%)
Tobins Q-Ratio = 0.16 (Enterprise Value 31.60b / Total Assets 195.15b)
Interest Expense / Debt = 1.50% (Interest Expense 691.0m / Debt 45.95b)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = -14.31b (EBIT -19.08b * (1 - 25.00%)) [loss with tax shield]
Current Ratio = 1.02 (Total Current Assets 80.54b / Total Current Liabilities 78.74b)
Debt / Equity = 0.86 (Debt 45.95b / totalStockholderEquity, last quarter 53.55b)
Debt / EBITDA = -1.60 (negative EBITDA) (Net Debt 15.80b / EBITDA -9.90b)
Debt / FCF = -1.15 (negative FCF - burning cash) (Net Debt 15.80b / FCF TTM -13.70b)
Total Stockholder Equity = 72.52b (last 4 quarters mean from totalStockholderEquity)
RoA = -9.21% (Net Income -18.51b / Total Assets 195.15b)
RoE = -25.53% (Net Income TTM -18.51b / Total Stockholder Equity 72.52b)
RoCE = -18.58% (EBIT -19.08b / Capital Employed (Equity 72.52b + L.T.Debt 30.19b))
RoIC = -13.12% (negative operating profit) (NOPAT -14.31b / Invested Capital 109.12b)
WACC = 3.46% (E(17.03b)/V(62.97b) * Re(9.76%) + D(45.95b)/V(62.97b) * Rd(1.50%) * (1-Tc(0.25)))
Discount Rate = 9.76% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.21%
[DCF] Fair Price = unknown (Cash Flow -13.70b)
EPS Correlation: -57.61 | EPS CAGR: -18.58% | SUE: -0.31 | # QB: 0
Revenue Correlation: -39.53 | Revenue CAGR: 20.77% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=0.20 | Chg7d=-0.160 | Chg30d=-1.350 | Revisions Net=+0 | Growth EPS=+147.6% | Growth Revenue=+4.7%
EPS next Year (2027-12-31): EPS=1.32 | Chg7d=-0.150 | Chg30d=-0.920 | Revisions Net=+0 | Growth EPS=+560.0% | Growth Revenue=+4.2%